Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06471751 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Strengthening Inspiratory and Oropharyngeal Muscles in Moderate Obstructive Sleep Apnea Hypopnea Syndrome

Study acronym: REMI SAHOS
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 12 months later Aug 1, 2026 → Aug 1, 2027
See other at-risk trials from Centre Hospitalier Universitaire de Saint Etienne

Record History

  1. Primary and study completion pushed from Aug 1, 2026 to Aug 1, 2027 Eligibility criteria expanded, about 85 words · Secondary endpoints: details revised at 2 of 7 entries · Collaborators: details revised at 1 of 2 entries Show 3 more changesShow less
    • Eligibility criteria expanded, about 85 words
    • Secondary endpoints: details revised at 2 of 7 entries
    • Collaborators: details revised at 1 of 2 entries
  2. Trial status: Not Yet Recruiting to Recruiting Start date changed from estimate of Dec 2024 to Dec 30, 2024 · Site details revised at 2 of 2 sitesv7 Show 2 more changesShow less
    • Start date changed from estimate of Dec 2024 to Dec 30, 2024
    • Site details revised at 2 of 2 sites
  3. Start date: Nov 2024 to Dec 2024v6
  4. Start date: Oct 2024 to Nov 2024v5
  5. Start date: Sep 2024 to Oct 2024v4
Show 2 earlier versionsHide 2 earlier versions
  1. Start date: Jul 2024 to Sep 2024v3
  2. Secondary endpoints revised (7)v2 See this version in full on ClinicalTrials.gov ↗
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The Obstructive Sleep Apnea hypopnea Syndrome (OSAS), whose prevalence is 4% of the French population, can lead to serious health consequences (risk of road accidents, onset of cardiovascular disease, etc.). OSAS corresponds to a certain number of interruptions (apneas) or reductions (hypopneas) of ventilation during sleep. The weakening of the tone of the inspiratory and oropharyngeal muscles is one of the main causes of upper airways obstruction during the inspiratory phase.
Trial Details
NCT Number NCT06471751
Lead Sponsor Centre Hospitalier Universitaire de Saint Etienne
Collaborators: Association aide à la recherche médicale de proximité (AIRE), Conseil national de l'ordre des masseurs-kinésithérapeutes
Conditions Obstructive Sleep Apnea
Enrollment 38 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov